Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents
- 22 September 1999
- journal article
- review article
- Published by Elsevier
- Vol. 3 (4) , 466-473
- https://doi.org/10.1016/s1367-5931(99)80068-4
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Isolation and Characterization of PDE8A, a Novel Human cAMP-Specific PhosphodiesteraseBiochemical and Biophysical Research Communications, 1998
- Cyclic Nucleotide Phosphodiesterase 4 Subtypes Are Differentially Expressed by Primary Keratinocytes and Human Epidermoid Cell LinesJournal of Investigative Dermatology, 1998
- Phosphodiesterase IsozymesAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Molecular Cloning and Expression of a Human Phosphodiesterase 4CCellular Signalling, 1997
- Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3Biochemical Journal, 1997
- Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D geneBiochemical Journal, 1997
- Type 4 phosphodiesterase inhibitors and their potential in the treatment of inflammatory diseaseEmerging Drugs, 1997
- Isolation of a cDNA encoding a human rolipram-sensitive cyclic AMP phosphodiesterase (PDE IVD)Gene, 1994
- The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV) reveals a multigene familyGene, 1993
- A low-Km, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. Cloning and expression of cDNA, biochemical characterization of recombinant protein, and tissue distribution of mRNA.Published by Elsevier ,1993